参考文献/References:
[1] Yellon DM,Hausenloy DJ.Myocardial reperfusion injury[J].N Engl J Med,2007,357(11):1121-1135.
[2] Hausenloy DJ,Yellon DM.Myocradial ischemia-Reperfusion injury:a neglected therapeutic target[J]. J Clin Invest,2013,123(1):92-100.
[3] Zhang T,Zhang Y,Cui M,et al.?CaMKⅡ is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis [J].Nat Med,2016,22(2):175-182.
[4] Touboul C,Angoulvant D,Mewton N,et al.Ischaemic postconditioning reduces infarct size: systematic review and meta-analysis of randomized controlled trials[J]. Arch Cardiovasc Dis,2015,108(1):39-49.
[5] Wang Z,Chen Q,Guo H,et al. Effects of dexmedetomidine on H-FABP,CK-MB,cTnI levels,neurological function and near-term prognosis in patients undergoing heart valve replacement[J]. Exp Ther Med,2017,14(6):5851-5856.
[6] Frangogiannis NG. The inflammatory response in myocardial injury,repair,and remodelling[J]. Nat Rev Cardiol ,2014,11(5):255-265.
[7] Li J,Xie C,Zhuang J,et al.?Resveratrol attenuates inflammation in the rat heart subjected to ischemia-reperfusion:role of the TLR4/NF-κB signaling pathway[J].?Mol Med Rep,2015,11(2):1120-1126.
[8] Yaoita H,Ogawa K,Maehara K,et al. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor[J]. Circulation,1998,97(3):276-281.
[9] Koshinuma S,Miyamae M,Kaneda K,et al. Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia–reperfusion injury[J]. J Anesth,2014,28(2):235-241.
[10] Dmitriev YV,Minasian SM,Demchenko EA,et al. Study of cardioprotective effects of necroptosis inhibitors on isolated rat heart subjected to global ischemia-reperfusion[J].?Bull Exp Biol Med,2013,155(2):245-248.
[11] Yang Y,Jiang K,Liu X,et al. CaMKⅡ in regulation of cell death during myocardial reperfusion injury [J].Front Mol Biosci,2021,8:668129.
[12] Jiang H,Xing J,Fang J,et al.Tilianin protects against ischemia/reperfusion-induced myocardial injury through the inhibition of the ca2+/calmodulin-dependent protein kinase Ⅱ-dependent apoptotic and inflammatory signaling pathways[J].Biomed Res Int,2020,2020:5939715.
相似文献/References:
[1]阎萌,田芳,综述,等.程序性坏死与动脉粥样硬化[J].心血管病学进展,2016,(2):139.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.011]
YAN Meng,TIAN Fang,TIAN Ye.Necroptosis and Atherosclerosis[J].Advances in Cardiovascular Diseases,2016,(12):139.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.011]
[2]付辉,黄鹤.线粒体功能障碍在心血管疾病中的作用[J].心血管病学进展,2020,(3):306.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.022]
FU Hui,HUANG He.Role of Mitochondrial Dysfunction in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(12):306.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.022]
[3]韩敏 朱兵 余嘉清 马依彤.程序性细胞死亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(10):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
HAN MinZHU BingYU JiaqingMA Yitong.  Programmed Cell Death and Myocardial Ischemic Reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(12):1069.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.017]
[4]张彩霞 曾彬 廖小婷.心肌梗死模型中三碘甲状腺原氨酸对心肌的保护作用研究[J].心血管病学进展,2020,(11):1209.[doi:10.16806/j.cnki.issn.1004-3934.20.11.000]
ZHANG Caixia,ZENG Bin,LIAO Xiaoting.Protective Effect of Triiodothyronine on Myocardium in Myocardial Infarction Model[J].Advances in Cardiovascular Diseases,2020,(12):1209.[doi:10.16806/j.cnki.issn.1004-3934.20.11.000]
[5]郭双 邢栋 吕勃.程序性坏死、细胞焦亡与心肌缺血再灌注损伤[J].心血管病学进展,2020,(12):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
GUO Shuang,XING Dong,LYU Bo.NecroptosisPyroptosis and Myocardial Ischemia-reperfusion Injury[J].Advances in Cardiovascular Diseases,2020,(12):1255.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.008]
[6]杨帆 吴建军.五味子乙素通过半胱天冬酶凋亡途径对抗高糖诱导的心肌细胞氧化应激损伤[J].心血管病学进展,2022,(2):188.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.022]
YANG Fan,WU Jianjun.Sch.B Protects High Glucose-Induced Cardiomyocytes from Oxidative Stress Injury via Caspase Pathway[J].Advances in Cardiovascular Diseases,2022,(12):188.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.022]
[7]曹兴丹 陈子仪 宋小刚 张玉秀 陈敏 汤吉超 李萍萍 陈永清 荆哲.EMRE在高糖环境中的变化对心肌细胞凋亡机制的研究[J].心血管病学进展,2022,(10):953.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.020]
CAO XingdanCHEN ZiyiSONG XiaogangZHANG YuxiuCHEN MinTANG JichaoLI PingpingCHEN YongqingJING Zhe.Effect of High Glucose-Induced EMRE Expressions Changes on?yocardial Apoptosis[J].Advances in Cardiovascular Diseases,2022,(12):953.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.020]
[8]高璐阳 金旗 张毅 李欣 黄志华 章思铖 段安琪 赵智慧 赵青 罗勤 柳志红.PI3K/Akt/FoxO1信号通路对人源肺动脉平滑肌细胞及肺动脉高压大鼠细胞凋亡的影响[J].心血管病学进展,2024,(1):79.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.020]
GAO Luyang,JIN Qi,ZHANG Yi,et al.Effect of PI3K/Akt/FoxO1 Signaling Pathway on Apoptosis in Human Pulmonary Artery Smooth Muscle Cell and Pulmonary Hypertension Rat[J].Advances in Cardiovascular Diseases,2024,(12):79.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.020]
[9]李铭,高继先,吴冰,等.卡格列净减轻心肌梗死后细胞凋亡及炎症反应改善预后[J].心血管病学进展,2024,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.018]
LI Ming,GAO Jixian,WU Bing,et al.Canagliflozin alleviates apoptosis and inflammation after myocardial infarction, and improves prognosis[J].Advances in Cardiovascular Diseases,2024,(12):368.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.018]
[10]文江艳 滕藤 唐其柱.黄杞苷减轻H9c2细胞的缺氧再复氧损伤[J].心血管病学进展,2024,(6):566.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.020]
WEN Jiangyan,TENG Teng,TANG Qizhu.Engeletin Alleviates Hypoxia Reoxygenation Injury in H9c2 Cells[J].Advances in Cardiovascular Diseases,2024,(12):566.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.020]